Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Roaring Internet Stocks -- Ignore unavailable to you. Want to Upgrade?

To: Don Savage who wrote (748)	1/8/1999 11:43:00 AM
From: GARY P GROBBEL	Read Replies (3) \| Respond to of 1530

SCEP...presently .28/.35 on 75,000...up .06...this is a burgeoning area for internet sales...this just out: Medisys Technologies, Inc. Concludes Internet Agreement BATON ROUGE, La. and LARGO, Fla.--(BUSINESS WIRE)--Jan. 8, 1999-- Medisys® Technologies, Inc., (Medisys®) (OTC BB:SCEP - news) announced an exclusive agreement with Health Rewards Inc. (http://www.health-rewards.com) to provide health products for internet marketing to the growing US marketplace for Nutriceuticals. The Phillips Pharmatech (PPL) Division of Medisys will produce a wide range of health products that will be sold through the Internet by Health Rewards. ''The Health Rewards line is focused on products that address the three biggest concerns of consumers: heart disease, diabetes and obesity'', noted Steve Pohlit, Chairman of Health Rewards. (stevep@stevepohlit.com) Pohlit strongly believes that one of the categories pegged for success on the Internet is products that can be purchased for value and convenience and directly affect individuals overall health. Brett Phillips, President of PPL commented, ''This agreement continues our efforts to align with the most innovative and forward looking business partners. We expect much of our future business to be through electronic commerce''. Medisys® Technologies, Inc. has thirteen U.S. patents covering these safety devices and other products. The Company also has over 20 patent applications pending for protection of medical devices both in the United States and overseas in the areas of women's health, lifeline management, medical safety and other specialty revenue markets. The PPL business unit currently produces nutritional, health and dietary products as well as pharmaceuticals with consistent profitability and 1997 sales of approximately $3.6 Million. Phillips manufactures over 350 products for a customer base of over 100 nutriceutical and pharmaceutical companies that market to major drug, food, health and wellness chains throughout the U.S. PPL is a contract manufacturer business unit owned and operated under the name and public umbrella of Medisys® Technologies, Inc. PPL provides Medisys® with general revenue and cash flow during the development phase of its over 20 patented medical devices. Statements in this release may be construed to be forward looking and are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that all forward looking statements involve risks and uncertainties, including, but not limited to, risks associated with regulatory approvals, lack of adequate capitalization and/or other risks inherent in medical device and other product development. Contact: Ed Sutherland/Kerry Frey